Clade Therapeutics cuts staff and appears to shut down European subsidiary
Clade Therapeutics, which is developing off-the-shelf cell therapies, has dismissed a number of staffers in the US and Europe, according to social media posts made …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.